Screener
Bio-Rad Laboratories BIO Debt Repayments
Debt Repayments at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Proceeds from maturities of marketable securities and investments | 17.7 | 19.5 |
| Net cash provided by (used in) investing activities | (93.2) | 2.9 |
| Cash flows from financing activities: | ||
| Payments on long-term debt | (0.1) | (0.1) |
| Proceeds from issuance of common stock and from reissuance of treasury stock under the employee stock purchase plan and upon exercise of stock options | 3.4 | 4.3 |
| Payments for purchases of treasury stock | (47.8) | (101.9) |
| Option premium proceeds for structured purchases of treasury stock | 0.5 | — |
| Net cash used in financing activities | (44.0) | (97.7) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bio-Rad Laboratories's debt repayments?
- Bio-Rad Laboratories (BIO) reported debt repayments of $100K in Q1 2026.
- How has Bio-Rad Laboratories's debt repayments changed year-over-year?
- Bio-Rad Laboratories's debt repayments decreased by 0.0% year-over-year, from $100K to $100K.
- What is the long-term trend for Bio-Rad Laboratories's debt repayments?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories's debt repayments has grown at a -36.2% compound annual growth rate (CAGR), from $3.02M to $500K.
- What does debt repayments mean?
- Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.
Ask your AI about Bio-Rad Laboratories's debt repayments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude